The Effectiveness of Biofeedback Treatment in Constipated Patients With Idiopathic Parkinson's Disease
- Conditions
- Idiopathic Parkinson's DiseaseConstipation
- Interventions
- Other: biofeedback therapy
- Registration Number
- NCT00869830
- Lead Sponsor
- Asan Medical Center
- Brief Summary
The aims of the investigators' study are to characterize the nature of constipation in idiopathic Parkinson's disease (IPD) and to evaluate the usefulness of biofeedback therapy in constipated IPD patients.
- Detailed Description
The medical treatment of idiopathic Parkinson's disease (IPD) alleviates constipation symptoms due to the restoration of autonomic dysfunction. However, additional laxatives are usually needed in these patients. Other suppository treatments included stool softeners, dopamine-receptor agonists, botulinum toxins, and prokinetic medications such as tegaserod. Biofeedback therapy (BFT) has been the gold standard for functional constipation with dyssynergic defecation or rectal hyposensitivity. However, researchers have not tried to evaluate its usefulness in constipated IPD patients up to now. The aims of our study are to characterize the nature of constipation in IPD and to evaluate the usefulness of BFT in constipated IPD patients.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
- Idiopathic Parkinson's disease
- Secondary Parkinson's disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description biofeedback biofeedback therapy -
- Primary Outcome Measures
Name Time Method To evaluate the effectiveness of biofeedback therapy in Parkinson's disease usually six sessions per one biofeedback for 3 months
- Secondary Outcome Measures
Name Time Method to evaluate the constipation type in Parkinson's disease 3-6 months
Trial Locations
- Locations (1)
Seung-Jae, Myung
🇰🇷Seoul, Korea, Republic of